December 11, 2018
Mitsubishi Tanabe Pharma said on December 10 that its US subsidiary has launched a study to identify specific biomarkers for assessing the disease progression of amyotrophic lateral sclerosis (ALS) and the efficacy of its medicine edaravone, known as Radicava in...read more